Mobile Carbapenemase Genes in Pseudomonas aeruginosa
EJ Yoon, SH Jeong - Frontiers in microbiology, 2021 - frontiersin.org
Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical
settings impelling a great challenge to antimicrobial therapy for patients with infections …
settings impelling a great challenge to antimicrobial therapy for patients with infections …
Epidemiology and mechanisms of resistance of extensively drug resistant Gram-negative bacteria
EM Eichenberger, JT Thaden - Antibiotics, 2019 - mdpi.com
Antibiotic resistance has increased markedly in gram-negative bacteria over the last two
decades, and in many cases has been associated with increased mortality and healthcare …
decades, and in many cases has been associated with increased mortality and healthcare …
The increasing threat of Pseudomonas aeruginosa high-risk clones
The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …
The epidemiology of carbapenemases in Latin America and the Caribbean
K Escandón-Vargas, S Reyes, S Gutiérrez… - Expert review of anti …, 2017 - Taylor & Francis
ABSTRACT Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp.
infections are major causes of morbidity and mortality, especially due to the emergence and …
infections are major causes of morbidity and mortality, especially due to the emergence and …
Prevalencia y factores de riesgo para infecciones del tracto urinario de inicio en la comunidad causadas por Escherichia coli productor de betalactamasas de …
Introducción Las infecciones del tracto urinario (ITU) son frecuentes en la comunidad. Sin
embargo, la información de aislamientos resistentes en este contexto es limitada en …
embargo, la información de aislamientos resistentes en este contexto es limitada en …
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from …
AC Gales, G Stone, DF Sahm… - Journal of Antimicrobial …, 2023 - academic.oup.com
Objectives To assess the global and regional distribution of ESBLs in Enterobacterales and
carbapenemases in Enterobacterales and Pseudomonas aeruginosa. Methods …
carbapenemases in Enterobacterales and Pseudomonas aeruginosa. Methods …
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam …
KM Kazmierczak, DJ Biedenbach… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The Klebsiella pneumoniae carbapenemase (KPC), first described in the United States in
1996, is now a widespread global problem in several Gram-negative species. A worldwide …
1996, is now a widespread global problem in several Gram-negative species. A worldwide …
[HTML][HTML] Distribución y caracterización molecular de betalactamasas en bacterias Gram negativas en Colombia, 2001-2016
AM Rada, C Hernández-Gómez, E Restrepo… - Biomédica, 2019 - scielo.org.co
Las betalactamasas, enzimas con capacidad hidrolítica frente a los antibióticos
betalactámicos, son responsables del principal mecanismo de resistencia en bacterias …
betalactámicos, son responsables del principal mecanismo de resistencia en bacterias …
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals
Ceftazidime-avibactam (CZA) is the combination of a third-generation cephalosporin and a
new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β …
new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β …
Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying blaVIM–2 and blaKPC–2 Genes That Spread on Different Genetic …
AM Rada, E De La Cadena, CA Agudelo… - Frontiers in …, 2021 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with an increase in
the frequency of infections caused by multidrug resistant (MDR) and extensively drug …
the frequency of infections caused by multidrug resistant (MDR) and extensively drug …